Randomised control study evaluating the efficacy and the intestinal microbiota by perioperative administration of probiotics for liver transplant recipients

Randomised control study evaluating the efficacy and the intestinal microbiota by perioperative administration of probiotics for liver transplant recipients - Randomised control study evaluating the efficacy and the intestinal microbiota by perioperative administration of probiotics for liver transplant recipients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024009

Enrollment

Registered

2016-09-15

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplant recipient

Interventions

Administration of probiotics for 2 months or until discharge whichever longer. Clostridium butyricum MIYAIRI 3g/day No treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Liver transplant recipiets >= 20 years old Eligible for enteral feeding Written informed consent

Exclusion criteria

Exclusion criteria: Those Who has a history of allergy to the drug Those whom attending doctors regarded as inappropriate as candidates

Design outcomes

Primary

Measure	Time frame
surgical complications including infection, rejection, prognosis	—

Secondary

Measure	Time frame
Laboratory test results including blood examination and microbiological examination Vital signs Prognosis	—

Countries

Japan

Contacts

Public ContactMiki Nagao

Kyoto University Hospital Department of clinical laboraoty

ict@kuhp.kyoto-u.ac.jp075-751-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026